JP2023014282A - Information processor, server, information processing method, and program - Google Patents

Abstract

PROBLEM TO BE SOLVED: To provide a display device for displaying clinical examination values that allow a user to efficiently grasp information necessary for a prescription audit of a prescription prescribed for a patient.

SOLUTION: A display device for displaying clinical examination values includes: grouping means that receives pharmaceuticals described on a prescription and the clinical examination values and groups the clinical examination values on the basis of a relationship between the pharmaceuticals and the clinical examination values; and display means that distinguishably displays the grouped clinical examination values on a display section. In the display device for displaying the clinical examination values, the grouping classifies the clinical examination values into different groups for each pharmaceutical.

SELECTED DRAWING: Figure 3

COPYRIGHT: (C)2023,JPO&INPIT

Description

The present invention relates to a display device, a server, a display method, and a program for displaying clinical test values.

The development of information processing technology has widely permeated medical institutions such as pharmacies that dispense and provide medicines, increasing convenience. For example, computers such as receipt computers that support the preparation of medical bills (medical bills) have long been known in medical institutions. ing. Moreover, in recent years, systems that electronically manage patient information such as medication history have become widespread.

In the past, the receipt computer and the system for managing the medication history were hardware-independent computers. An operatively linked pharmacy computer is disclosed.

JP 2011-118535 A

By the way, when dispensing medicines to patients, prescription audits are conducted to confirm whether there is any doubt in delivering the medicines as they are based on the items written in the prescriptions, patient information, medication history, and the like. In such a prescription audit, there are cases where reference is made to clinical laboratory test values that can grasp the patient's condition of injury or disease and the effects of drugs being taken. However, there are a large number of laboratory test values, and even if a large number of input clinical test values are randomly displayed, it is not possible to efficiently grasp the desired information on injuries and diseases and medicines. As a result, even if information such as clinical laboratory test values is displayed for prescription audits, it is impossible to efficiently search for necessary clinical laboratory test value information, making it impossible to quickly conduct appropriate prescription audits.

SUMMARY OF THE INVENTION The present invention has been made in view of such circumstances, and provides a display device and a program for displaying laboratory test values that can efficiently grasp the information necessary for prescription audit for a prescription prescribed to a patient. With the goal.

(1) grouping means for receiving drugs and laboratory test values described in a prescription, grouping the relevant laboratory test values based on the relationship between the drug and the laboratory test values; and display means for displaying on the display unit in a distinguishable manner.

(2) The display device for displaying clinical test values according to (1), wherein the grouping may classify one clinical test value into different groups for each drug.

(3) The display device for displaying clinical test values according to (1) or (2), wherein the grouping is performed for each drug effect and drug side effect.

(4) The display device for displaying laboratory test values according to (3), wherein the grouping may be classified into the side effect portion of the drug when the value of the laboratory test value is a predetermined value.

(5) the display means displays clinical test values having the relationship with the drug and clinical test values not having the relationship with the drug in response to receiving the selection of the drug; A display device for displaying a clinical test value according to any one of (1) to (4).

(6) The display device for displaying clinical test values according to any one of (1) to (5), wherein the display means displays the clinical test values by distinguishing between locations where the clinical test values are obtained.

(7) a grouping step of receiving the drugs and laboratory test values described in the prescription and grouping the relevant laboratory test values based on the relationship between the drugs and the laboratory test values; and a display step of displaying on the display section in a distinguishable manner.

Selection of the drug column, the prescription audit related information column, and the intersection column may be performed by accepting the selection of one of the columns and displaying specific information. selection, selection of only intersection fields, selection of drug fields and prescription audit-related information fields, selection of drug fields and prescription audit-related information fields, selection of prescription audit-related information fields and intersection fields, or drug fields and prescription audit-related fields Specific information may be displayed by selecting the information column and the cross column.

ADVANTAGE OF THE INVENTION According to this invention, the information required for the prescription audit|inspection with respect to the prescription prescribed to the patient can be grasped|ascertained efficiently.

1 is a diagram showing the configuration of a display system that displays clinical test values; FIG. It is a figure which shows the outline|summary of medicine provision business. FIG. 3 is a block diagram showing the functional configuration of a display device that displays clinical test values; It is a figure which shows patient DB of a memory|storage part. It is a figure which shows clinical test value DB of a memory|storage part. It is a figure which shows attached document DB of a memory|storage part. FIG. 4 is a diagram showing an example of a display screen displayed on a display device that displays clinical test values; FIG. 4 is a diagram showing an example of a display screen displayed on a display device that displays clinical test values; 4 is a flow chart showing the flow of processing of a display system for displaying laboratory test values. FIG. 3 is a block diagram showing the functional configuration of a display device that displays clinical test values; It is a figure which shows patient DB of a memory|storage part. FIG. 4 is a diagram showing an example of a display screen displayed on a display device that displays clinical test values;

One embodiment of the present invention will be described below with reference to the drawings.

[First embodiment]
[Configuration of display system 100 for displaying clinical test values]
Referring to FIG. 1, a display system 100 for displaying clinical test values of the present invention includes display devices 2a . . . and a display 3 for informing the progress of the drug provision work.

The display devices 2a . . . 2n for displaying the laboratory test values are terminal devices used by the person in charge of each task constituting the medicine providing service.
Here, referring to FIG. 2 (1), the drug providing service dispenses the drug according to the prescription after receiving the prescription from the patient at the window, and if the dispensing is deemed appropriate in the final audit, It consists of a series of flows such as providing the drug to the patient at the counter. As an example of such drug provision work, each work shown in FIG. ”, ”dispensing”, ”final audit”, and ”drug delivery accounting”. Some of these works can proceed independently of each other, and in this embodiment, these works are divided among a plurality of persons in charge. For example, pharmacist A is in charge of "reception", "patient information collection", "dispensing", and "drug delivery accounting" among the work that constitutes drug provision work, and "medication history confirmation", "prescription audit", "dispensing design", " The pharmacist B is in charge of the explanation about taking the medicine and the decision of dispensing, and the pharmacist C is in charge of the final inspection.
In this embodiment, for example, the display device 2a that displays the clinical test values is used by the pharmacist A, the display device 2b that displays the clinical test values is used by the pharmacist B, and the display device that displays the clinical test values is used. 2c will be used by pharmacist C. Of course, the display devices 2a . . . 2n for displaying clinical test values may not only be used by one person in charge, but may also be shared by a plurality of persons in charge. Since the display devices 2a . . . 2n for displaying clinical test values have basically the same configuration, they may be hereinafter simply referred to as "display devices 2 for displaying clinical test values".

The administrator device 1 is a terminal device that is used by an administrator who manages each person in charge and has administrator authority to extend, change, limit, etc. the functions of the display device 2 that displays clinical test values. It is a general-purpose personal computer equipped with an input unit realized by a keyboard, a touch panel, etc., and a display unit by a display, in addition to a control unit that performs operations and a storage unit that stores various information.

The display device 2 for displaying clinical test values is intended to support the operations of pharmacies in a multifaceted manner, and is implemented by a general-purpose personal computer like the administrator device 1 . Various programs are installed in the display device 2 that displays such clinical test values, and the control unit operates according to these programs to perform a receipt computer function, a medication history management function, a task sharing function, and a prescription audit. ”, it exhibits the function of displaying clinical test values. Laboratory test values are referred to when assessing the patient's condition of injury or disease and the degree of influence of drugs, and refer to values obtained by qualitatively or quantitatively measuring components, cells, etc. contained in the patient. In pharmacies, it is referred to in order to grasp whether the drug is sufficiently effective and whether side effects of the drug have occurred by "prescription audit".
The administrator device 1 and the display device 2 for displaying laboratory test values are connected by a predetermined network line, and cooperate with each other to support the work of providing drugs to patients.

The display 3 is arranged so as to face the patient visiting the pharmacy, and displays the progress of the drug providing work to the patient. The display 3 is communicably connected to the administrator device 1 and/or the display device 2 that displays the clinical test values, and according to instructions from the administrator device 1 and/or the display device 2 that displays the clinical test values, the progress status display.

[Functional Configuration of Display Device 2 for Displaying Laboratory Test Values]
Next, the configuration of the display device 2 that displays clinical test values will be described with reference to FIG. The display device 2 for displaying clinical test values includes reception means 211 , extraction means 212 , grouping means 213 , and display means 214 in the control section 21 , and patient DB 221 and , a clinical test value DB 222 and an attached document DB 223 .

The receiving means 211 receives the content of the prescription and the clinical test values of the patient at the time of the patient's specific hospital visit, and stores the content of the prescription and the clinical test values in the patient DB 221 in association with the patient ID.
Here, the contents of the prescription are information about the contents described in the prescription and information accompanying receipt of the prescription, such as specific information of the patient such as the patient's name, prescription drug indicating the prescribed drug and date of receipt, which indicates the date the pharmacy received the prescription, and first administration, which indicates whether the drug described in the prescription was prescribed to the patient for the first time.
In addition, clinical test values include, for example, blood pressure, pulse, and other biological tests related to the patient's condition, blood sugar levels, red blood cell counts, urinary protein, γ-GTP, and other components and cells that the patient has of specimen tests are stored.
The contents of the prescription and clinical test values received by the receiving means 211 are used when the extracting means 212 extracts the contents of the patient's past prescriptions and clinical test values, or when the grouping means 213 groups the clinical test values, as described later. It is used when

The extracting means 212 extracts from the patient DB the contents of past prescriptions associated with the patient ID of the patient who received the prescription and the types and values of laboratory test values. The extracting means 212 also extracts from the clinical test value DB 222 the relationship between the drug contained in the received prescription content and the clinical test value based on the received prescription content and the type and value of the clinical test value.

Also, the patient DB 221 will be described with reference to FIG. The patient DB 221 stores the contents of prescriptions and clinical test values received at the pharmacy, and stores the contents of prescriptions and clinical test values received by the receiving means 211 in association with patient IDs. The patient DB 221 stores a “patient ID” that stores information identifying a patient, a “patient name” that stores the name of the patient, a “receipt date” that stores the date the prescription was received, and a prescription that is the content of the received prescription. configured to have a "drug" in which the received drug is stored, a "clinical test value item" in which the type of the accepted clinical test value is stored, and a "clinical test value" in which the received clinical test value is stored It is As the value of "clinical test value", in addition to a quantitative value such as a specific number, a qualitative value indicating the presence or absence of the clinical test value is stored. For example, for the clinical laboratory test value of systolic blood pressure, a quantitative value of 95 mgHG was stored, and for the clinical laboratory test value of urinary protein, the clinical laboratory test value was detected as presence/absence. A qualitative value is stored indicating that In addition to the above information, the patient DB 221 may include information relating to the patient's personal information, drug information, and laboratory test value information.

Also, the clinical test value DB 222 will be described with reference to FIG. The laboratory test value DB 222 is a DB having a relationship table that stores the relationship between types and values of drugs and clinical test values, and a normal value table that stores normal values of the clinical test values. The relationship table includes "drug" that is drug information, "clinical test value item" that stores the type of clinical test value, "clinical test value" that stores the value of the clinical test value, and drug and clinical test value information. A "relationship" is stored, which is the relationship between the type and the value. The normal value table stores laboratory test values and their normal values.
In addition to such information, the clinical test value DB 222 may include other information regarding the relationship between the drug and the clinical test value. The normal value table may be configured to have different normal values depending on gender, age, and the like.
Here, the "relationship" is specifically information indicating the relationship between the clinical laboratory test values for the drug. Information indicating that there is a relationship "drug effect" is stored. Further, for example, information is stored that the laboratory test value γ-GTP for the antihypertensive agent A has a relationship of “drug side effect”. In addition, such relationships are not limited to drug effects and side effects, and may include three or more relationships. You may establish a relationship such as Here, the term “off-label” means that the drug is used for the purpose of treating symptoms that are not included in the approval content of the drug.
Further, the "relationship" may be configured so that the relationship changes depending on the value even for the same type of drug and laboratory test value. For example, information is stored that the laboratory test value of systolic blood pressure for a drug called antihypertensive agent A has a relationship of "drug effect". Information is also stored that there is a relationship of "side effects of In this case, for antihypertensive agent A, if the systolic blood pressure exceeds 100 mgHG, the systolic blood pressure is classified only as "drug effect", but if the systolic blood pressure is 100 mgHG or less, the systolic blood pressure is classified as "drug effect" and "drug effect". It is classified as "side effects of drugs".

Also, with reference to FIG. 6, the attached document DB 223 will be described. The package insert DB 223 stores drug package insert data in association with each item of the drug. A package insert is a product information document for doctors and medical institutions that describes the drug name, precautions for use, item specifications and other important matters. The package insert DB 223 stores, in correspondence with the items of the package insert, information such as drug names, efficacy and effects indicating indications and dosages, precautions for use, side effects, and the like. In addition to the information described in the package insert, items other than the package insert, such as long-term administration check drugs and high-risk drugs, may be provided, although not shown in the figure.

The grouping means 213 groups the clinical test values for each drug based on the relationship between the drugs and the clinical test values extracted by the extracting means 212 .
Here, the reason why the grouping means 213 groups clinical test values for each drug will be described. In order to conduct a prescription audit to confirm whether there are any doubts about the delivery of the drug as it is based on the information on the prescription, patient information, medication history, etc.・Referring to clinical test values that can understand the effects of the drugs you are taking may be done. However, there are a large number of laboratory test values, and even if all laboratory test values for which information was obtained are displayed during prescription audits, some laboratory test values that are not affected by the prescribed drug are included. there is In this way, if the clinical test values that are not affected by taking the drug are displayed, there is a risk that the clinical test values that should be grasped during prescription audits may not be grasped, or it may take time to grasp them. In addition, even if the laboratory test values are affected by drug use, if the laboratory test values related to drug efficacy and drug side effects are mixed, the pharmacist may not be able to confirm the clinical test values when conducting prescription audits. cannot be grasped intuitively.
Therefore, the display device 2 for displaying the clinical test values displays the clinical test values affected by the drug, and groups the clinical test values for each drug based on the relationship between the drug and the clinical test values for display. conduct.

Specifically, a process of grouping clinical test values by drug by the grouping unit 213 based on the relationship between the drug and the clinical test value will be described as an example. In this embodiment, for example, the grouping means 213 classifies the systolic blood pressure, the pulse, the γ-GTP, and the blood sugar level, which are the extracted laboratory test values of the patient A, as the systolic blood pressure, the diastolic blood pressure, and the pulse for the drug A. grouped as “effect of In addition, patient A has a systolic blood pressure of 90 mgHG, so for drug A, systolic blood pressure and γ-GTP are grouped as "drug side effects."
Here, systolic blood pressure, diastolic blood pressure, and pulse were grouped together as "drug effect", but the relationship between drug A and pulse is "drug effect (not indicated)", so systolic blood pressure And the diastolic blood pressure may be set as the "drug effect", and the pulse as the "drug effect (not indicated)" may be grouped separately from the "drug effect".

The display means 214 groups the clinical test values based on the contents of the prescription and the clinical test values received by the receiving means 211 and the clinical test values and the relationship extracted by the extracting means 212, so that each clinical test value is classified into a drug and a clinical test value. Data for a display screen configured to be distinguishable for each relationship with the inspection value is generated and displayed on the display unit 24 . Further, the display unit 214 displays the drug administration period based on the content of the received prescription and the content of the past prescription extracted by the extraction unit 212 . Further, in response to receiving the selection of the drug displayed from the input unit 23, the display means 214 limits the clinical test values to those related to the drug, groups the clinical test values, and groups the clinical test values so that each clinical test value corresponds to the drug. Data for a display screen configured to be distinguishable for each relationship with clinical test values is generated and displayed on the display unit 24 .

Here, display screen data displayed on the display unit 24 by the display unit 214 will be described with reference to FIG. FIG. 7 is a diagram showing that the display screen data generated by the display means 214 is displayed on the display unit 24. The displayed screen is a screen in which the pharmacist "Taro Higashi" audits the prescription of the patient "A". This is an example of a display screen displayed when the pharmacist "Taro Higashi" selects "medicine A" when performing By referring to this screen, the pharmacist conducts a prescription inspection and confirms the contents of the prescription based on the items described in the prescription, patient information/medication history, and laboratory test values.

The display area V1 is a screen that illustrates the medication period of the prescribed medicine. In the display area V1, the horizontal axis displays the date, and the vertical axis displays the content of the prescription received by the receiving means 211 and the medicines prescribed in the past. A bar indicating the period during which the drug was prescribed is displayed in the center. For example, B1 indicates that drug B is prescribed for 7 days from May 1st. In addition, when the taking period of a prescribed drug overlaps with the taking period of a prescription drug before or after it, the bars are shifted vertically so that the bars do not overlap, and the taking period is displayed. A bar is displayed below the overlapping period. For example, like B2, the bar indicating 21 days of drug A prescribed on April 16 is shifted upward, and the bar indicating 30 days of drug A prescribed on May 1 is shifted downward. The dates are now offset, and a bar is displayed to indicate overlap between May 1st and May 6th.
In response to receiving the selection of each of the drugs displayed in the display area V1, a clinical test value related to the selected drug is displayed in the display area V2, which will be described later.

The display areas V2, V3, and V4 display the clinical test values of the prescribed drug in a distinguishable manner. V2, V3, and V4 in FIG. 7 receive the selection of the drug A, and display the clinical test values related to the drug A in a distinguishable manner for each relationship.
In the display area V2, laboratory test values whose relationship with the drug A is "drug effect" are displayed. For example, in the display area V2, the systolic blood pressure, the diastolic blood pressure, and the pulse rate whose relationship with the drug A is "drug effect" are displayed in the same group. Further, in the display area V3, clinical test values whose relationship with the drug A is "drug side effects" are displayed. For example, systolic blood pressure, γ-GTP, and urinary protein, which are related to drug A as "drug side effects", are displayed in the same group. In addition, the systolic blood pressure displayed in "Side effects of drugs" is displayed in "Side effects of drugs" because the value on May 1 is 100 or less, but when the value of systolic blood pressure is 100 or less Systolic blood pressure is not displayed in "side effects of drugs" without

The display area V4 accepts the selection of the drug A, and displays laboratory test values that are not related to the drug A. FIG. For example, fasting blood glucose and HbA1C, which are not affected by drug A, are displayed in the same group.

Display areas V2, V3, and V4 display graphs showing changes in the respective laboratory test values. The horizontal axis of the graph shows the month and day, and the vertical axis of the graph shows the values of clinical test values. In addition, in the center of the graph, the normal value range indicating the normal values of the laboratory test values is shown, and the quantitative laboratory test values are displayed as a diagram. It's becoming In addition, qualitative laboratory test values are displayed as +- so that the presence or absence thereof can be identified.
Here, the month and day on the horizontal axis can be changed by pressing a scale enlargement or reduction button, and can be changed from daily to weekly or monthly. In addition, the clinical test values on the vertical axis are displayed by extracting the normal values of the clinical test values to be displayed from the clinical test value DB 222. is adjusted and displayed. For example, the systolic blood pressure, diastolic blood pressure, and pulse displayed on V3 are 100-129, 60-79, and 50-90, respectively. The values of the axis scale (the lower limit of the scale, the interval between the scales and the upper limit of the scale) are adjusted to be different for each clinical test value.

Thus, the need for the vertical axis to have the same normal range display will be explained with reference to the simplified FIG.
In V5 of FIG. 8, the systolic blood pressure and the diastolic blood pressure are displayed, but the scales of the respective laboratory test values are displayed in the same scale, and the normal value ranges are displayed differently. However, when displayed in this way, there is a problem that it is difficult to intuitively understand which line diagram showing which laboratory test value corresponds to the normal value range. The more , the more difficult it becomes to understand intuitively.
Therefore, in the display device 2 that displays the clinical test values, the scale values are adjusted so that the normal value ranges are the same for different types of clinical test values.
It should be noted that the display of FIG. 7 and the display of FIG. 8 may be switched to each other by accepting a user's selection.

[Operation of display device 2 displaying clinical test values]
Next, the operation of the display device 2 for displaying clinical test values will be described with reference to FIG.
First, the receiving means 211 receives prescription contents and/or laboratory test values (step S1). After that, the receiving means 211 associates the contents of the received prescription and/or clinical test values with the patient ID, and stores them in the patient DB 221 (step S2). After that, the extracting means 212 extracts the past prescription content, clinical test values, and information on the relationship between the drugs and the clinical test values necessary for generating the display image data (step S3). After that, the grouping means 213 groups the clinical test values for each drug based on the relationship between the drugs and the clinical test values extracted by the extracting means 212 (step S4). After that, the display means 214 groups the clinical test values based on the contents of the prescription and the clinical test values received by the receiving means 211 and the clinical test values and relationships extracted by the extracting means 212, and the respective clinical test values are the drugs. Data for a display screen are generated so that they can be distinguished for each relationship between the data and clinical test values (step S5). After that, the display means 214 outputs the data of the generated display screen to the display section 24 (step S6).

After that, the accepting means 211 accepts the selection of medicine (step S7). After that, the display unit 214 generates display screen data limited to the clinical test values related to the selected drug in response to the reception unit 211 accepting the selection of the drug (step S8). After that, the display means 214 outputs the generated display screen data to the display section 24 (step S9).

As described above, in the present embodiment, only laboratory test values related to the prescribed drug are displayed without displaying clinical test values that are not affected by the prescribed drug. It is possible to appropriately grasp the efficacy and side effects of the drug taken, and to efficiently grasp the information necessary for the prescription audit of the prescription prescribed to the patient.

In addition, in this embodiment, only laboratory test values related to the prescribed drug are displayed without displaying clinical test values that are not affected by the prescribed drug. Effectiveness and side effects can be properly grasped, and information necessary for prescription audits of prescriptions prescribed to patients can be efficiently grasped.

In addition, in the present embodiment, among the prescribed drugs, only the clinical test values related to the drug selected by the pharmacist are displayed without displaying the clinical test values that are not affected by the drug selected by the pharmacist. Therefore, pharmacists can appropriately grasp which drugs among the prescribed drugs affect clinical test values and cause efficacy and side effects. Necessary information can be grasped efficiently.

In addition, in the present embodiment, only laboratory test values related to the prescribed drug are displayed without displaying laboratory test values that are not affected by the prescribed drug. are displayed differently, the pharmacist can intuitively grasp the meaning of the clinical laboratory test values displayed among the prescribed drugs, and the information necessary for prescription audits of prescriptions prescribed to patients can be efficiently obtained. can be grasped.

[Second embodiment]
In the first embodiment, the display device 2 has reception means 211, extraction means 212, grouping means 213, and display means 214 in the control section 21, and patient DB 221 and , a clinical test value DB 222 and an attached document DB 223 .
On the other hand, in the present embodiment, as shown in FIG. 10, the control unit 21 includes reception means 211a, extraction means 212, grouping means 213, display means 214a, and display switching reception means 215. One area of the storage unit 22 has a patient DB 221a, a clinical test value DB 222, and an attached document DB 223. FIG.
The functional configuration of this embodiment will be described below. Descriptions of functions similar to those of the first embodiment will be omitted.

The receiving means 211a receives the contents of the prescription at the time of the patient's specific hospital visit, the patient's clinical test values, and the acquisition location of the clinical test values, and associates the contents of the prescription, the clinical test values, and the acquisition location of the clinical test values with the patient ID. is stored in the patient DB 221a.
The receiving means 211a indicates the acquisition location of the clinical test values, whether the entity that acquired the clinical test values is a medical institution or a patient, etc., and if the entity that acquired the clinical test values is a medical institution, the type of the medical institution. Accept as distinguishable.

Also, the patient DB 221a will be described with reference to FIG. The patient DB 221a stores the contents of prescriptions and clinical test values received at the pharmacy, and stores the contents of prescriptions and clinical test values received by the receiving means 211 in association with patient IDs. The patient DB 221a includes a "patient ID" that stores information identifying the patient, a "patient name" that stores the patient's name, a "receipt date" that stores the date when the prescription was received, and a prescription that is the content of the received prescription. In addition to "medicine" in which the received drug is stored, "clinical test value item" in which the type of accepted clinical test value is stored, and "clinical test value" in which the accepted clinical test value is stored, "clinical "Examination Acquisition Location".

Returning to FIG. 10, the display switching reception means 215 receives the display method of the clinical test values, and displays the display of the clinical test values on the display unit 24 according to the received display method.
Specifically, the display switching reception unit 215 receives a display method for clinical test values. The display method of the clinical test values is a display method as to whether or not to distinguish and display the clinical test values according to the acquisition location. As for the display method of the clinical laboratory test values, when the values are to be displayed separately, the method of the distinction is selected. For the display method of laboratory test values, for example, one of "not distinguish", "discriminate and change the display depending on the location", "discriminate and display only medical institutions", and "discriminate and display only home" can be selected. accept.

The display means 214a groups the clinical test values based on the contents of the prescription and the clinical test values received by the receiving means 211 and the clinical test values and the relationship extracted by the extracting means 212, and identifies the respective clinical test values as drugs and clinical data. Data for a display screen configured to be distinguishable for each relationship with the inspection value is generated and displayed on the display unit 24 . The display unit 214a displays the clinical test values according to the display method accepted by the display switching acceptance unit 215. FIG.

Here, the display screen data displayed on the display section 24 by the display means 214a will be described with reference to FIG. FIG. 12 is a diagram showing that the display screen data generated by the display means 214a is displayed on the display section 24. As shown in FIG. Note that points in common with the first embodiment will be briefly described.

FIG. 12(1) shows display data generated by the display unit 214a when the display switching reception unit 215 receives "do not distinguish".
In the display area V2a, "not discriminate" is selected, so the systolic blood pressure clinical test values are displayed as the diagram L1 regardless of the location where they were obtained.
FIG. 12(2) shows display data generated by the display unit 214a when the display switching reception unit 215 receives "distinguish/change the display depending on the location".
In the display area V2a, "distinguish/change the display depending on the location" is selected, so the systolic blood pressure laboratory test value obtained at the clinic α is displayed as a diagram L2, and the obtained location is at home. The systolic blood pressure laboratory value is displayed as diagram L3.
FIG. 12(3) shows display data generated by the display means 214a when the display switching reception means 215 receives "distinguish/display only medical institutions".
Since "distinguish/display only medical institution" is selected in the display area V2a, the systolic blood pressure laboratory test value acquired at the clinic α is displayed as a diagram L4. Note that the systolic blood pressure laboratory test value acquired at home is excluded from the diagram L4, but only the mark is displayed.

In this way, by displaying the clinical test values by distinguishing the places where the clinical test values are obtained, it is possible to appropriately grasp the efficacy and side effects of the prescribed drug.
For example, the systolic blood pressure may be displayed as higher than the original blood pressure due to the patient being tense when measured by a medical staff. Therefore, the pharmacist can grasp the original systolic blood pressure by distinguishing and displaying the place where the systolic blood pressure was obtained.

As described above, in the present embodiment, clinical test values can be displayed by distinguishing the places where the clinical test values are obtained, so that the pharmacist can appropriately grasp the efficacy and side effects of the prescribed drug. It is possible to efficiently grasp the information necessary for the prescription audit for the prescription prescribed to the patient.

It should be noted that the present invention is not limited to the above-described embodiments, and includes modifications, improvements, and the like within the scope of achieving the object of the present invention.

Also, the present invention can be applied to a terminal device having the functional configuration shown in FIG. At this time, to have the functional configuration shown in FIG. Including possible states. That is, the present invention can also be applied to so-called ASP services that provide business applications to customers via the Internet.

In addition, in the present embodiment, clinical laboratory test values displayed by selecting a drug are displayed based on a group based on the relationship with the selected drug. Laboratory values may be displayed based on their relationship to all drugs. In addition, by selecting items of clinical test values or diagrams on the graph, a drug having a relationship with the selected clinical test value may be clearly displayed. Here, the display in which the drugs are clarified means that, for example, only drugs having a relationship may be displayed on the display unit, or the display color of the drugs having a relationship may be different from that of other drugs. It may be displayed to be emphasized.

In addition, in the present embodiment, the clinical test values that are not related to the drug are displayed in the display area V4, but the present invention is not limited to this. You may make it not display an inspection value.

Further, in the present invention, the clinical test values received by the receiving means 211 are not limited by the medical institution from which they are obtained. For example, it may be a clinical test value obtained at a pharmacy where the display device 2 is installed, or a clinical test value obtained at a medical institution other than the pharmacy where the display device 2 is installed.
The clinical test values obtained at other medical institutions that are received by the receiving means 211 are not limited to the clinical test values that the person in charge hears and inputs from the patient, and may be received from other medical institutions via a network line.

The series of processes described above can be executed by hardware or by software.
In other words, the functional configuration of FIG. 3 is merely an example and is not particularly limited. In other words, it is sufficient for the computer to have a function capable of executing the series of processes described above as a whole, and what kind of functional blocks are used to realize this function is not particularly limited to the example in FIG.
Also, one functional block may be composed of hardware alone, software alone, or a combination thereof.

When a series of processes is to be executed by software, a program constituting the software is installed in a computer or the like from a network or a recording medium.
The computer may be a computer built into dedicated hardware. The computer may also be a computer capable of executing various functions by installing various programs, such as a general-purpose personal computer.

1 administrator device 2 display device for displaying clinical test values 3 display 21 control unit 22 storage unit 23 input unit 24 display unit 211 reception means 212 extraction means 213 grouping means 214 display means 221 patient DB
222 Laboratory test value DB
223 Attachment DB

The present invention relates to an information processing device , a server, an information processing method, and a program.

Claims (13)

A patient database that accepts input of patient's laboratory test values and stores information including drugs described in the patient's prescription and the clinical test values of the patient is associated with the received clinical test values of the patient. a memorizing reception means;
extracting means for extracting from the patient database the clinical test values having at least one of a plurality of types of relationships including drug effects and drug side effects with respect to at least one drug described in a patient's prescription; ,
display means for displaying at least one of the clinical test values extracted by the extraction means and changes in the clinical test values on a screen displaying information about the patient's prescription;
A display device for displaying laboratory test values. The display means displays at least one of the clinical test values extracted by the extracting means and changes in the clinical test values for each drug described in the prescription and the clinical data extracted by the extracting means. 2. The display device for displaying clinical test values according to claim 1, wherein the relationship with the test values is displayed in a distinguishable display form. grouping means for grouping the laboratory test values based on the type of the relationship with the drug;
3. The display device for displaying clinical test values according to claim 1, wherein said display means displays said grouped clinical test values in a distinguishable manner for each group. In the grouping, one clinical test value may be classified into different groups for each drug,
A display device for displaying the clinical test value according to claim 3. The grouping is performed for each effect of the drug and side effects of the drug,
A display device for displaying the clinical test values according to claim 3 or 4. In the grouping, if the laboratory test value is a predetermined value, it may be classified into the side effect group of the drug.
A display device for displaying the clinical test value according to claim 5. The display means, in response to receiving a selection of one of the displayed drugs, displays the clinical test value having the relationship with the selected drug, and the selected drug. displaying the laboratory test values that do not have the relationship;
A display device for displaying the clinical test values according to any one of claims 1 to 6. The display means displays the clinical test values by distinguishing between locations where the clinical test values were obtained.
A display device for displaying the clinical test values according to any one of claims 1 to 7. a patient database that stores information including drugs listed in a patient's prescription and laboratory test values for the patient;
reception information storage means for storing in the patient database in association with the patient a clinical test value transmitted from a terminal device that receives input of a patient's clinical test value;
extracting means for extracting, from the patient database, the clinical test values having at least one of a plurality of types of relationships including drug effects and drug side effects with respect to at least one of the drugs transmitted from the terminal device; ,
display information transmission means for transmitting information for displaying at least one of the clinical test values extracted by the extraction means and changes in the clinical test values to the terminal device on a screen displaying information about the patient's prescription; When,
A server with A method of displaying laboratory test values performed by a display device,
A patient database that accepts input of patient's laboratory test values and stores information including drugs described in the patient's prescription and the clinical test values of the patient is associated with the received clinical test values of the patient. a memorized reception step;
an extracting step of extracting from the patient database the laboratory test values having at least one of a plurality of types of relationships including drug efficacy and drug side effects with respect to at least one of the drugs described in the patient's prescription; ,
a display step of displaying at least one of the clinical test values extracted in the extraction step and changes in the clinical test values on a screen displaying information about the patient's prescription;
How to display laboratory test values, including A method for displaying laboratory test values performed by a server, comprising:
The server is provided with a patient database that stores information including the drug described in the patient's prescription and the patient's laboratory test value,
a reception information storage step of correlating clinical test values transmitted from a terminal device for receiving input of patient's clinical test values with the patient and storing them in the patient database;
an extracting step of extracting, from the patient database, the clinical test values having at least one of a plurality of relationships including drug effects and drug side effects with respect to at least one of the drugs transmitted from the terminal device; ,
A display information transmission step of transmitting information for displaying at least one of the clinical test values extracted in the extracting step and changes in the clinical test values to the terminal device on a screen displaying information related to the patient's prescription. When,
How to display laboratory test values, including to the computer,
A patient database that accepts input of patient's laboratory test values and stores information including drugs described in the patient's prescription and the clinical test values of the patient is associated with the received clinical test values of the patient. a memorized reception function;
an extracting function for extracting from the patient database the laboratory test values having at least one of a plurality of types of relationships including drug efficacy and drug side effects with respect to at least one drug described in a patient's prescription; ,
a display function for displaying at least one of the clinical test values extracted by the extraction function and changes in the clinical test values on the screen displaying information about the patient's prescription;
program to realize In a computer comprising a patient database storing information including drugs specified in a patient's prescription and laboratory test values for the patient;
a reception information storage function for storing in the patient database in association with the patient the clinical test values transmitted from a terminal device that receives the input of the patient's clinical test values;
an extracting function for extracting from the patient database the clinical test values having at least one of a plurality of types of relationships including drug effects and drug side effects with respect to at least one of the drugs transmitted from the terminal device; ,
A display information transmission function for transmitting information for displaying at least one of the clinical test values extracted by the extraction function and changes in the clinical test values to the terminal device on a screen displaying information about the patient's prescription. When,
program to realize

Images